- Home
- IGC vs ONMD Comparison
IGC vs ONMD Comparison
Compare IGC & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- ONMD
- Stock Information
- Founded
- IGC 2005
- ONMD 2006
- Country
- IGC United States
- ONMD United States
- Employees
- IGC N/A
- ONMD N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- ONMD
- Sector
- IGC Health Care
- ONMD
- Exchange
- IGC Nasdaq
- ONMD Nasdaq
- Market Cap
- IGC 39.8M
- ONMD 43.5M
- IPO Year
- IGC N/A
- ONMD N/A
- Fundamental
- Price
- IGC $0.40
- ONMD $2.33
- Analyst Decision
- IGC Strong Buy
- ONMD
- Analyst Count
- IGC 2
- ONMD 0
- Target Price
- IGC $4.00
- ONMD N/A
- AVG Volume (30 Days)
- IGC 886.9K
- ONMD 17.6M
- Earning Date
- IGC 11-14-2025
- ONMD 12-16-2025
- Dividend Yield
- IGC N/A
- ONMD N/A
- EPS Growth
- IGC N/A
- ONMD N/A
- EPS
- IGC N/A
- ONMD N/A
- Revenue
- IGC $1,327,000.00
- ONMD $459,000.00
- Revenue This Year
- IGC $3.54
- ONMD N/A
- Revenue Next Year
- IGC $15.12
- ONMD N/A
- P/E Ratio
- IGC N/A
- ONMD N/A
- Revenue Growth
- IGC 24.95
- ONMD N/A
- 52 Week Low
- IGC $0.25
- ONMD $0.30
- 52 Week High
- IGC $0.50
- ONMD $4.22
- Technical
- Relative Strength Index (RSI)
- IGC 46.88
- ONMD 56.84
- Support Level
- IGC $0.36
- ONMD $2.10
- Resistance Level
- IGC $0.43
- ONMD $2.40
- Average True Range (ATR)
- IGC 0.02
- ONMD 0.31
- MACD
- IGC 0.00
- ONMD -0.09
- Stochastic Oscillator
- IGC 46.64
- ONMD 23.66
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
About ONMD OneMedNet Corp
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its innovative solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's innovative technology proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols and paves the way for Real World Evidence.